632 related articles for article (PubMed ID: 29719281)
1. Expression of Nrf2 Promotes Schwann Cell-Mediated Sciatic Nerve Recovery in Diabetic Peripheral Neuropathy.
Tang W; Chen X; Liu H; Lv Q; Zou J; Shi Y; Liu Z
Cell Physiol Biochem; 2018; 46(5):1879-1894. PubMed ID: 29719281
[TBL] [Abstract][Full Text] [Related]
2. Schwann cells apoptosis is induced by high glucose in diabetic peripheral neuropathy.
Liu YP; Shao SJ; Guo HD
Life Sci; 2020 May; 248():117459. PubMed ID: 32092332
[TBL] [Abstract][Full Text] [Related]
3. Diabetic Schwann cells suffer from nerve growth factor and neurotrophin-3 underproduction and poor associability with axons.
Dey I; Midha N; Singh G; Forsyth A; Walsh SK; Singh B; Kumar R; Toth C; Midha R
Glia; 2013 Dec; 61(12):1990-9. PubMed ID: 24123456
[TBL] [Abstract][Full Text] [Related]
4. miRNA-155 silencing reduces sciatic nerve injury in diabetic peripheral neuropathy.
Chen J; Li C; Liu W; Yan B; Hu X; Yang F
J Mol Endocrinol; 2019 Oct; 63(3):227-238. PubMed ID: 31404910
[TBL] [Abstract][Full Text] [Related]
5. Curcumin accelerates the repair of sciatic nerve injury in rats through reducing Schwann cells apoptosis and promoting myelinization.
Zhao Z; Li X; Li Q
Biomed Pharmacother; 2017 Aug; 92():1103-1110. PubMed ID: 28622711
[TBL] [Abstract][Full Text] [Related]
6. Schwann cell O-GlcNAcylation promotes peripheral nerve remyelination via attenuation of the AP-1 transcription factor JUN.
Kim S; Maynard JC; Strickland A; Burlingame AL; Milbrandt J
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):8019-8024. PubMed ID: 30012597
[TBL] [Abstract][Full Text] [Related]
7. Taurine protects against myelin damage of sciatic nerve in diabetic peripheral neuropathy rats by controlling apoptosis of schwann cells via NGF/Akt/GSK3β pathway.
Li K; Shi X; Luo M; Inam-U-Llah ; Wu P; Zhang M; Zhang C; Li Q; Wang Y; Piao F
Exp Cell Res; 2019 Oct; 383(2):111557. PubMed ID: 31415759
[TBL] [Abstract][Full Text] [Related]
8. Electroacupuncture improves peripheral neuropathy by up-regulating Sirt1/PGC-1α/TFAM pathway in type 2 diabetes rats with peripheral neuropathy.
Yuan CX; Wang X; Yu Z; Lian XY; Xu B
Zhen Ci Yan Jiu; 2024 Apr; 49(4):349-357. PubMed ID: 38649202
[TBL] [Abstract][Full Text] [Related]
9. Translocator protein alleviates allodynia and improves Schwann cell function against diabetic peripheral neuropathy via activation of the Nrf2-dependent antioxidant system and promoting autophagy.
Gao N; Ma B; Jia H; Hao C; Jin T; Liu X
Diabet Med; 2023 Jun; 40(6):e15090. PubMed ID: 37013248
[TBL] [Abstract][Full Text] [Related]
10. Lipin1 Alleviates Autophagy Disorder in Sciatic Nerve and Improves Diabetic Peripheral Neuropathy.
Wang M; Xie M; Yu S; Shang P; Zhang C; Han X; Fan C; Chen L; Zhuang X; Chen S
Mol Neurobiol; 2021 Nov; 58(11):6049-6061. PubMed ID: 34435332
[TBL] [Abstract][Full Text] [Related]
11. CHOP/ORP150 ratio in endoplasmic reticulum stress: a new mechanism for diabetic peripheral neuropathy.
Wu YB; Li HQ; Ren MS; Li WT; Lv XY; Wang L
Cell Physiol Biochem; 2013; 32(2):367-79. PubMed ID: 23988440
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of moxibustion simultaneously targeting Nrf2 and NF-κB in diabetic peripheral neuropathy.
Li J; Hu X; Liang F; Liu J; Zhou H; Liu J; Wang H; Tang H
Appl Biochem Biotechnol; 2019 Dec; 189(4):1167-1182. PubMed ID: 31209719
[TBL] [Abstract][Full Text] [Related]
13. GLP‑1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NF‑κB signaling pathways in streptozotocin‑induced diabetic rats.
Ma J; Shi M; Zhang X; Liu X; Chen J; Zhang R; Wang X; Zhang H
Int J Mol Med; 2018 May; 41(5):2977-2985. PubMed ID: 29484377
[TBL] [Abstract][Full Text] [Related]
14. TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression.
Zhang X; Zhao S; Yuan Q; Zhu L; Li F; Wang H; Kong D; Hao J
Cell Death Dis; 2021 Jun; 12(7):642. PubMed ID: 34162834
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Effect of Salvianolic Acid A against Diabetic Peripheral Neuropathy through Modulation of Nrf2.
Xu C; Hou B; He P; Ma P; Yang X; Yang X; Zhang L; Qiang G; Li W; Du G
Oxid Med Cell Longev; 2020; 2020():6431459. PubMed ID: 32184918
[TBL] [Abstract][Full Text] [Related]
16. Fisetin Imparts Neuroprotection in Experimental Diabetic Neuropathy by Modulating Nrf2 and NF-κB Pathways.
Sandireddy R; Yerra VG; Komirishetti P; Areti A; Kumar A
Cell Mol Neurobiol; 2016 Aug; 36(6):883-892. PubMed ID: 26399251
[TBL] [Abstract][Full Text] [Related]
17. Sodium phenylbutyrate inhibits Schwann cell inflammation via HDAC and NFκB to promote axonal regeneration and remyelination.
Yadav A; Huang TC; Chen SH; Ramasamy TS; Hsueh YY; Lin SP; Lu FI; Liu YH; Wu CC
J Neuroinflammation; 2021 Oct; 18(1):238. PubMed ID: 34656124
[TBL] [Abstract][Full Text] [Related]
18. Neural Progenitor-Like Cells Induced from Human Gingiva-Derived Mesenchymal Stem Cells Regulate Myelination of Schwann Cells in Rat Sciatic Nerve Regeneration.
Zhang Q; Nguyen P; Xu Q; Park W; Lee S; Furuhashi A; Le AD
Stem Cells Transl Med; 2017 Feb; 6(2):458-470. PubMed ID: 28191764
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats.
Samii A; Unger J; Lange W
Neurosci Lett; 1999 Mar; 262(3):159-62. PubMed ID: 10218880
[TBL] [Abstract][Full Text] [Related]
20. Diphenyl diselenide alleviates diabetic peripheral neuropathy in rats with streptozotocin-induced diabetes by modulating oxidative stress.
Wang X; Huan Y; Li C; Cao H; Sun S; Lei L; Liu Q; Liu S; Ji W; Liu H; Huang K; Zhou J; Shen Z
Biochem Pharmacol; 2020 Dec; 182():114221. PubMed ID: 32949583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
